Dublin-based Allergan has confirmed that it is in "preliminary friendly discussions regarding a potential business combination transaction" with Pfizer. Allergan, which manufactures Botox, would not comment on speculation regarding the terms of a potential transaction and said that no agreement had been reached yet.
Yesterday, the Wall Street Journal reported that the companies were considering a merger. The deal could be among the largest in the drug industry’s history and give Pfizer control of the...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team